IS6150A - Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun - Google Patents

Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun

Info

Publication number
IS6150A
IS6150A IS6150A IS6150A IS6150A IS 6150 A IS6150 A IS 6150A IS 6150 A IS6150 A IS 6150A IS 6150 A IS6150 A IS 6150A IS 6150 A IS6150 A IS 6150A
Authority
IS
Iceland
Prior art keywords
supercalcium
nutritional
prevention
treatment
pharmaceutical compositions
Prior art date
Application number
IS6150A
Other languages
English (en)
Inventor
De Simone Claudio
Original Assignee
Actial Farmacêutica LDA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmacêutica LDA filed Critical Actial Farmacêutica LDA
Publication of IS6150A publication Critical patent/IS6150A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IS6150A 1999-05-28 2001-11-08 Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun IS6150A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
PCT/IT2000/000213 WO2000072855A2 (en) 1999-05-28 2000-05-24 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria

Publications (1)

Publication Number Publication Date
IS6150A true IS6150A (is) 2001-11-08

Family

ID=11406789

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6150A IS6150A (is) 1999-05-28 2001-11-08 Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun

Country Status (34)

Country Link
US (2) US6562336B2 (is)
EP (1) EP1181027B1 (is)
JP (1) JP4737836B2 (is)
KR (1) KR100781703B1 (is)
CN (1) CN100350919C (is)
AR (1) AR024555A1 (is)
AT (1) ATE265857T1 (is)
AU (1) AU773459B2 (is)
BR (1) BR0011038B1 (is)
CA (1) CA2373255C (is)
CZ (1) CZ20014076A3 (is)
DE (1) DE60010456T2 (is)
DK (1) DK1181027T3 (is)
DZ (1) DZ3165A1 (is)
EA (1) EA004257B1 (is)
EE (1) EE200100618A (is)
ES (1) ES2219344T3 (is)
HK (1) HK1048066B (is)
HU (1) HU225134B1 (is)
IL (3) IL146703A0 (is)
IS (1) IS6150A (is)
IT (1) IT1309427B1 (is)
MA (1) MA26790A1 (is)
MX (1) MXPA01012184A (is)
NO (1) NO20015782L (is)
NZ (1) NZ516020A (is)
PL (1) PL352014A1 (is)
PT (1) PT1181027E (is)
SI (1) SI1181027T1 (is)
SK (1) SK16612001A3 (is)
TR (1) TR200103439T2 (is)
UA (1) UA71621C2 (is)
WO (1) WO2000072855A2 (is)
ZA (1) ZA200110504B (is)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
KR20060028426A (ko) * 2003-06-24 2006-03-29 오츠카 세이야쿠 가부시키가이샤 혈청 요산치 감소용 조성물
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
EP1732395B1 (en) * 2004-03-19 2015-07-29 DuPont Nutrition Biosciences ApS Emulsified probiotic product
WO2006047680A2 (en) * 2004-10-27 2006-05-04 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
JP4938005B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
AU2005339139A1 (en) 2005-12-14 2007-06-21 Oxthera, Inc. Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2007075447A2 (en) 2005-12-16 2007-07-05 Oxthera, Inc. Compositions and methods for oxalate reduction
CN101636173A (zh) * 2007-03-27 2010-01-27 宝洁公司 施用益生菌剂的方法及试剂盒
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿系统结石药物中的应用
US9283252B2 (en) 2008-09-30 2016-03-15 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
CN101554237B (zh) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 植物纤维或微生物不溶组分中的草酸降解酶的制备方法
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) * 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
JP5765832B2 (ja) * 2013-12-26 2015-08-19 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
WO2016051358A1 (en) * 2014-10-01 2016-04-07 Triphase Pharmaceuticals Pvt. Ltd. Thermo-stable strains, products and methods thereof
ITUB20155752A1 (it) * 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
CN107868776A (zh) 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 糖基化草酸脱羧酶及其制备和应用
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
KR20210125988A (ko) * 2018-12-10 2021-10-19 노봄 바이오테크놀로지스, 인크. 고옥살산뇨증을 치료하기 위한 방법 및 조성물
CN113308416B (zh) * 2021-07-20 2023-02-24 四川大学 一株具有抑制肾结石形成能力的植物乳杆菌及其应用
CN115851508B (zh) * 2022-10-13 2024-01-09 山东中科嘉亿生物工程有限公司 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
DK0768375T4 (da) * 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
EP0856259B1 (en) * 1996-12-23 1998-08-12 SITIA-YOMO S.p.A. Composition for feed use comprising lyophilized live lactic bacteria
JP4996780B2 (ja) * 1997-05-23 2012-08-08 オクセラ インコーポレイテッド シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
RU2139346C1 (ru) * 1999-03-02 1999-10-10 Шендеров Борис Аркадьевич Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии

Also Published As

Publication number Publication date
JP2003500451A (ja) 2003-01-07
IL146703A0 (en) 2002-07-25
CA2373255C (en) 2010-01-19
ATE265857T1 (de) 2004-05-15
BR0011038B1 (pt) 2014-02-18
WO2000072855A2 (en) 2000-12-07
AR024555A1 (es) 2002-10-16
EA004257B1 (ru) 2004-02-26
HK1048066A1 (en) 2003-03-21
EA200101262A1 (ru) 2002-04-25
CN100350919C (zh) 2007-11-28
CN1365284A (zh) 2002-08-21
ZA200110504B (en) 2002-09-25
IT1309427B1 (it) 2002-01-23
KR20020019918A (ko) 2002-03-13
DE60010456T2 (de) 2005-05-12
CZ20014076A3 (cs) 2002-03-13
UA71621C2 (en) 2004-12-15
CA2373255A1 (en) 2000-12-07
BR0011038A (pt) 2002-02-26
ITRM990338A0 (it) 1999-05-28
DE60010456D1 (de) 2004-06-09
PT1181027E (pt) 2004-09-30
HK1048066B (zh) 2008-08-01
ES2219344T3 (es) 2004-12-01
ITRM990338A1 (it) 2000-11-28
EE200100618A (et) 2003-02-17
US6562336B2 (en) 2003-05-13
TR200103439T2 (tr) 2002-06-21
SI1181027T1 (en) 2004-08-31
NO20015782L (no) 2002-01-25
DK1181027T3 (da) 2004-08-16
AU773459B2 (en) 2004-05-27
EP1181027A2 (en) 2002-02-27
IL146703A (en) 2010-03-28
NO20015782D0 (no) 2001-11-27
IL199437A0 (en) 2011-07-31
USRE39585E1 (en) 2007-04-24
EP1181027B1 (en) 2004-05-06
DZ3165A1 (fr) 2000-12-07
MA26790A1 (fr) 2004-12-20
PL352014A1 (en) 2003-07-14
HUP0201409A3 (en) 2004-10-28
IL199437A (en) 2016-10-31
SK16612001A3 (sk) 2002-04-04
AU5101600A (en) 2000-12-18
MXPA01012184A (es) 2003-06-30
US20020061292A1 (en) 2002-05-23
HUP0201409A2 (en) 2002-08-28
WO2000072855A3 (en) 2001-06-28
HU225134B1 (en) 2006-06-28
JP4737836B2 (ja) 2011-08-03
NZ516020A (en) 2003-06-30
KR100781703B1 (ko) 2007-12-03

Similar Documents

Publication Publication Date Title
IS6150A (is) Næringar- eða lyfjasamsetningar til nota við fyrirbyggingu eða meðhöndlun á ofurkalsíum oxalat myndun
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
NO20015175L (no) Farmasöytisk sammensetning
IL158041A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
HUP0105113A3 (en) Benzoheterocycles and their use as mek inhibitors and pharmaceutical compositions containing the compounds
GB9916536D0 (en) Nutritional or pharmaceutical compositions
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
IL161616A0 (en) Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
AP2003002907A0 (en) Liquid pharmaceutical composition.
IL159765A0 (en) Aryl substituted thiazolidinone derivatives and pharmaceutical compositions containing the same
DE60037666D1 (de) Mehrschichtige flüssige zusammensetzung
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL156812A0 (en) Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
EE05020B1 (et) Glburiidi ravimkoostis
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
IL157908A0 (en) Phthalazinone derivatives and pharmaceutical compositions containing the same
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
ZA200203077B (en) Ciclesonide contained pharmaceutical composition for application to mucosa.
IL162743A0 (en) Tricyclic 2-pyrimidone derivatives and pharmaceutical compositions containing the same
IS7275A (is) Samsetning fyrir hollegg og notkun á henni
DE60033117D1 (de) Verhinderung des Festklebens von Hartkonfekten
HUP0102159A3 (en) Pharmaceutical composition for the treatment of rumen acidosis
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus